Terminal 18q deletions are stabilized by neotelomeres
© Guilherme et al.; licensee BioMed Central. 2015
Received: 26 February 2015
Accepted: 14 April 2015
Published: 13 May 2015
All human chromosomes are capped by tandem repeat (TTAGGG)n sequences that protect them against end-to-end fusion and are essential to chromosomal replication and integrity. Therefore, after a chromosomal breakage, the deleted chromosomes must be stabilized by retaining the telomere or acquiring a new cap, by telomere healing or telomere capture. There are few reports with molecular approaches on the mechanisms involved in stabilization of 18q terminal deletions.
In this study we analyzed nine patients with 18q terminal deletion identified by G-banding and genomic array. FISH using PNA probe revealed telomeric signals in all deleted chromosomes tested. We fine-mapped breakpoints with customized arrays and sequenced six terminal deletion junctions. In all six deleted chromosomes sequenced, telomeric sequences were found directly attached to the breakpoints. Little or no microhomology was found at the breakpoints and none of the breaks sequenced were located in low copy repeat (LCR) regions, though repetitive elements were found around the breakpoints in five patients. One patient presented a more complex rearrangement with two deleted segments and an addition of 17 base pairs (bp).
We found that all six deleted chromosomes sequenced were probably stabilized by the healing mechanism leading to a neotelomere formation.
KeywordsTerminal 18q deletion Breakpoint sequencing Telomere healing Telomere capture Neotelomere Stabilization mechanism
While interstitial deletions involve two breaks in the same chromosome arm, terminal deletions are caused by only one break leading to genomic loss. Terminal deletions of the long arm of chromosome 18 produce a highly variable phenotype. Among the most commonly reported features are growth deficiency, microcephaly, facial and limb abnormalities, genitourinary malformations, neurological abnormalities, hearing abnormalities and developmental delay with intellectual disability [1,2]. The phenotypic variability is related to the heterogeneity of the deletion size and gene content . The deletions vary in size, but proximal breakpoints have been mainly described within bands 18q21.2 to 18q22.2, and does not correlate completely with the severity of clinical findings [3-5]. The region 18q22-q23 has been implicated as critical in development impairment but a deletion in this region leads only to a susceptibility to the clinical features, since not all patients with this region deleted have the same clinical findings [4-6].
All human chromosomes are capped with around 3-20 kb of tandem repeat (TTAGGG)n sequences and, immediately adjacent to this region, there is a segment of around 100-300 kb, the telomere-associated repeat (TAR) sequences . These TAR sequences share homology with other chromosome ends [8,9]. Chromosome specific DNA sequences are located proximal to the TAR sequences . Since telomeres are essential for chromosomal stabilization after breakage, the deleted chromosomes must retain the telomere or acquire a new cap [11,12]. Two main mechanisms were proposed to stabilize chromosome ends with terminal deletions: (1) telomere healing in which telomerase directly adds de novo telomeric repeats to unique nontelomeric DNA and (2) telomere capture in which the telomere is captured from another chromosome due to homology of sequence by a recombination-based mechanism, resulting in a derivative chromosome [11,13]. It is assumed that sequence homology of TAR regions between non-homologous chromosomes may influence telomere capture events . Due to the development of molecular techniques, a variety of cryptic telomeric aberrations has been identified and showed that many apparently pure terminal deletions are in fact terminal deletions stabilized as derivative chromosomes by telomere capture [2,14,15]. The mechanism by which telomerase first recognizes a telomere or a broken chromosomal end is unknown . Human genome subtelomeric regions are of particular interest in clinical cytogenetics, since they are the most gene-rich regions in the entire genome [13,16]. Therefore, characterization of telomeric regions is important for our understanding of the relationship between chromosome structure and function  and because chromosomal rearrangements involving telomeres result in a number of clinical conditions, including intellectual disability .
Thanks to recent advances in molecular genetic techniques, a better characterization of terminal deletions is possible [18,19]. The studies have demonstrated that several terminal deletions considered simple are not as simple as first thought and can present microduplication, inversion or addition of some base pairs, or they are in fact interstitial deletions. Sequencing of 18q terminal deletions may also help to understand the clinical variability presented by the patients. In this study we studied nine patients with 18q terminal deletions using G-banding, array techniques and FISH with telomeric probe. In six patients breakpoint sequencing was performed to determine the mechanisms involved in the stabilization of the deleted chromosome.
Nine patients (7 females and 2 males) with 18q terminal deletion, detected by conventional karyotyping using G-banding and/or genomic array, were selected for the study.
Breakpoint definition data using G-banding, SNP-array, custom array CGH and FISH results with PNA probe in patients with 18q terminal deletion
G-banding karyotype and SNP-array (Affymetrix)
Custom array CGH (Agilent)
Differences between the coordinates of breakpoints
46,XY,del(18)(q21.33)dn.arr 18q21.33q23(60,814,531-78,015,057) × 1
arr 18q21.33q23(60,814,632-78,015,147) × 1
46,XX,del(18)(q21.33)dn.arr 18q21.33q23(59,488,812-78,015,057) × 1
arr 18q21.33q23(59,488,412-78,015,147) × 1
46,XX,del(18)(q21.32)dn.arr 18q21.32q23(57,712,098-78,015,057) × 1
arr 18q21.32q23(57,714,859-78,015,147) × 1
46,XX,del(18)(q21.32)dn.arr 18q21.32q23(57,818,459-78,015,057) × 1
arr 18q21.32q23(57,814,054-78,015,147) × 1
46,XY,del(18)(q21.31)dn.arr 18q21.31q23(56,044,470-78,015,057) × 1
arr 18q21.31q23(56,046,905-78,015,147) × 1
46,XX,del(18)(q22.1)dn.arr 18q22.1q23(62,772,720-78,015,057) × 1
arr 18q22.1q23(62,769,761-78,015,147) × 1
46,XX,del(18)(q21.32)dn.arr 18q21.32q23(58,641,269-78,015,057) × 1
46,XX,del(18)(q21.32)dn.arr 18q21.32q23(58,938,942-78,015,057) × 1
arr 18q21.32q23(58,939,925-78,015,147) × 1
Recently, high-resolution genomic analysis in patients with 18q terminal deletions have revealed a high variability in breakpoints and deleted regions, pointing to a contiguous gene syndrome [16,20]. Array results showed breakpoints in four different bands in our patients: four out of eight at 18q21.32 (57,714,859-58,939,925), some very close to each other, two at 18q21.33 (59,488,412 and 60,814,632), one at 18q21.31 (56,046,905) and one at 18q22.1 (62,769,761).
In this study seven patients presented telomeric sequences (TTAGGG)n in the long arm of the deleted chromosomes as shown by FISH with telomere probe. The sequencing of 18q terminal deletions in six patients revealed that the breaks were probably stabilized by a healing mechanism in which the telomerase enzyme synthesized a de novo telomere in the truncated chromosome at the breakpoints creating a neotelomere. There are other cases described in the literature stabilized by the same mechanism in different chromosomes with terminal deletions [10,11,13,21,22]. Although the deletions stabilized by telomere capture from another chromosome forming a derivative chromosome reported in the literature presented with DNA single copy sequences from both chromosomes [10,15,23], the possibility of the capture of only the (TTAGGG)n telomere sequences of other chromosomes, simulating a neotelomere formation cannot be ruled out. Luo et al  studied three cases with 18q terminal deletion and observed that the breakpoints were distributed throughout the end of the chromosome, as previously described in other studies . In one of the cases, the stabilization mechanism was consistent with NHEJ between double-strand breaks in two different chromosomes .
Many factors may contribute to make some regions of the chromatin more susceptible to breaks and rearrangements, such as the presence of enriched tandem repeats at chromosome ends, fragile DNA sequences, LCRs, concentration of particular repetitive sequences and motif sequences [24-26].
None of the six breaks sequenced in our patients were mediated by LCRs since they were absent in the breakpoint regions. LCRs were also not observed flanking the breakpoints in patients with 9q and 4p deletions [10,21]. The analysis of the region around the breakpoints revealed that only in our patient 1, repetitive elements were not found.
Ballif et al  characterized breakpoint regions in four patients with 1p36 terminal deletion and found that all the breakpoints fall within repetitive DNA sequence elements. Bonaglia et al  observed that only 13 out of 22 breakpoints in chromosomes with 22q13 deletion fell inside repetitive elements. Yatsenko et al  sequenced 43 breakpoints within the 9q34 region and the analysis of these junctions revealed that they were concentrated in regions with a high incidence of repetitive elements. Similarly, some of the breakpoints from our patients (P2, P4′s second break, P5 and P6) were located inside repetitive elements. However, it is unclear how repetitive elements participate in recombination events or DNA replication and repair .
Few (1 – 3 bp) or no microhomology was found in the breakpoints in our six patients who had their breakpoint sequenced. Similar lengths of microhomology were detected at breakpoint junctions sequenced from 14 terminal deletions of different chromosome ends . In vitro studies have demonstrated that mammalian telomerase is capable of de novo telomere addition with as little as a single bp of homology or none to the template, suggesting that 3’ end pairing is not essential [28,29]. In fact, in a small proportion of terminal deletion breakpoints, microhomology was not found [12,13,21], similar to observed in our patient 4. Taking all these data, microhomology seems not to be essential for telomerase elongate truncated chromosomes.
The microhomology sequences in our five patients are homologous to (TTAGGG)n telomere repeats and may reflect the template-driven replication mechanism, in which the telomerase utilizes to replicate chromosome ends . However, the site of healing cannot be precisely identified due to the microhomology between telomeric and breakpoint 18q sequences. Patient 4 presented an unexpected 18q terminal deletion with addition of 17 bp followed by an interstitial deletion in the first break and a terminal deletion. This event is probably the result of multiple steps: two breaks causing interstitial deletion with the addition of 17 bp that was stabilized by NHEJ (non-homologous end joining) followed by 18q normal sequence and a third break resulting in a terminal deletion stabilized by healing mechanism leading to the rearrangement observed. Similar to our study, other studies also found unexpected rearrangements at the breakpoint junctions such as interstitial deletion, additional nucleotides and inversion [10-12,22,24].
Telomeric sequences must be present in both chromosome arm ends showing its importance to the stabilization of the chromosomes deleted. Breakpoint analysis is useful in elucidating the molecular mechanisms by which terminal deletions are stabilized. Few cases with terminal deletion 18q had their breakpoints determined at the base pair level. In our six patients with 18q breakpoint sequenced, telomeric sequences (TTAGGG)n attached directly in the breakpoint were found indicating chromosome stabilization by telomere healing mechanism originating a neotelomere. In four cases repetitive elements were present in the breakpoint junctions. One of the patients presented a more complex rearrangement suggesting that in rare cases stabilization of a terminal deletion is not as simple as first thought.
Classical and molecular cytogenetics
Chromosome analysis was performed first on 72-h lymphocyte cultures according to standard procedures. FISH (Fluorescence in situ Hybridization) using commercial probe Telomere PNA FISH Kit/FITC (Peptide nucleic acid) Dako® was performed according to manufacturing guidelines.
DNA was isolated from peripheral blood using Gentra Puregene kit (Qiagen Sciences Inc., Germantown, MD, USA). Samples were genotyped using the Affymetrix Genome-Wide Human SNP Nsp/Sty 6.0 array (Affymetrix Inc., Santa Clara, CA, USA) and data were analyzed with the Chromosome Analysis Suite (ChAS) Software (Affymetrix Inc., Santa Clara, Calif., USA), using annotation GRCh37/hg19. To define the breakpoints with a higher resolution, custom 8 × 60 K CGH-arrays (Agilent Technologies) were designed with probes targeting the breakpoints detected by clinical SNP-array (Affymetrix), using Agilents’ SureDesign program (https://earray.chem.agilent.com/suredesign/). The custom slides presented with a total of 62,976 probes targeted at 30 kb intervals surrounding the previously determined breakpoints. Control probes were also added for other chromosomes at a lower density. The unique identifiers (AMADIDs) for the array designs are 49352 and 67473 (designs available upon request). The experiments were performed according to manufacturing guidelines. The slides were scanned using DNA microarray Scanner with Surescan of high resolution (Agilent Technologies) and signal intensities were evaluated using Feature Extraction Standard Edition 126.96.36.199 (Agilent Technologies, Santa Clara, CA). Breakpoint’s analyses were performed using Agilent Cytogenomics software.
In order to amplify breakpoint junctions, unique sequence forward primers, complementary to the intact (non-deleted) 18q chromosomal region, were designed using Primer3 software (http://simgene.com/Primer3) (Additional file 1: Table S1). These primers were paired with a reverse primer complementary to the telomeric repeat sequence that has been used in other studies: TelR2 5’- TATGGATCCCTAACCCTGACCCTAACCC-‘3 (Flint et al, 1994; Luo et al. 2011). Long Range PCR (Takara®, Japan) was performed with 5.0 μl PCR buffer (10x), 4.0 μl dNTP (2.5 mM each), 5.0 μl of each primer (2 μM), 7.0 μl Betaine (5 M), 0.25 μl Ex Taq (5 U/μl) and 1.0 μl of DNA template (100 ng). PCR conditions for amplifying terminal deletions were: 94°C for 1 min; 10 cycles at 94°C for 30s, 65°C for 1 min (decreasing 1.0°C per cycle), 72°C for 3 min; 20 cycles at 94°C for 30s, 59°C for 1 min, 72°C for 3 min; and the final extension at 72°C for 5 min. PCR products were purified from 1.5% agarose gels using the QIAquick Gel extraction kit (Quiagen) and the breakpoint junctions were sequenced in ABI PRISM 3500xl genetic analyzer (Life Technologies). A male control DNA sample was used in parallel in every reaction and no amplification was obtained as expected. The sequence chromatograms were analyzed using BioEdit software.
DNA sequences from the PCR products were aligned to the human genome reference assembly (GRC37/hg19) using BLAT tool on the UCSC Genome browser (https://genome.ucsc.edu/). The regions flanking the breakpoints (200 bp) of each patient were analyzed using different programs to search for homologue sequence (BLAST), repetitive elements and low complexity sequences (RepeatMasker database version 4.0.5).
Informed consents were obtained from the patients’ parents according to the Research Ethics Committee of UNIFESP (CEP 0389/11).
This work was supported by grant 2012/51150-0 and 2012/15572-7, São Paulo Research Foundation (FAPESP).
- Kline AD, White ME, Wapner R, Rojas K, Biesecker LG, Kamholz J, et al. Molecular analysis of the 18q- syndrome–and correlation with phenotype. Am J Hum Genet. 1993;52(5):895–906.PubMed CentralPubMedGoogle Scholar
- Brkanac Z, Cody JD, Leach RJ, DuPont BR. Identification of cryptic rearrangements in patients with 18q- deletion syndrome. Am J Hum Genet. 1998;62(6):1500–6.View ArticlePubMed CentralPubMedGoogle Scholar
- Cody JD, Ghidoni PD, DuPont BR, Hale DE, Hilsenbeck SG, Stratton RF, et al. Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet. 1999;85(5):455–62.View ArticlePubMedGoogle Scholar
- Strathdee G, Zackai EH, Shapiro R, Kamholz J, Overhauser J. Analysis of clinical variation seen in patients with 18q terminal deletions. Am J Med Genet. 1995;59(4):476–83.View ArticlePubMedGoogle Scholar
- Cody JD, Hasi M, Soileau B, Heard P, Carter E, Sebold C, et al. Establishing a reference group for distal 18q-: clinical description and molecular basis. Hum Genet. 2014;133(2):199–209.View ArticlePubMed CentralPubMedGoogle Scholar
- Cody JD, Heard PL, Crandall AC, Carter EM, Li J, Hardies LJ, et al. Narrowing critical regions and determining penetrance for selected 18q- phenotypes. Am J Med Genet A. 2009;149A(7):1421–30.View ArticlePubMedGoogle Scholar
- Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A. 1988;85(18):6622–6.View ArticlePubMed CentralPubMedGoogle Scholar
- Brown WR, MacKinnon PJ, Villasante A, Spurr N, Buckle VJ, Dobson MJ. Structure and polymorphism of human telomere-associated DNA. Cell. 1990;63(1):119–32.View ArticlePubMedGoogle Scholar
- Flint J, Thomas K, Micklem G, Raynham H, Clark K, Doggett NA, et al. The relationship between chromosome structure and function at a human telomeric region. Nat Genet. 1997;15(3):252–7.View ArticlePubMedGoogle Scholar
- Yatsenko SA, Brundage EK, Roney EK, Cheung SW, Chinault AC, Lupski JR. Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome. Hum Mol Genet. 2009;18(11):1924–36.View ArticlePubMed CentralPubMedGoogle Scholar
- Varley H, Di S, Scherer SW, Royle NJ. Characterization of terminal deletions at 7q32 and 22q13.3 healed by De novo telomere addition. Am J Hum Genet. 2000;67(3):610–22.View ArticlePubMed CentralPubMedGoogle Scholar
- Ballif BC, Yu W, Shaw CA, Kashork CD, Shaffer LG. Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions. Hum Mol Genet. 2003;12(17):2153–65.View ArticlePubMedGoogle Scholar
- Flint J, Craddock CF, Villegas A, Bentley DP, Williams HJ, Galanello R, et al. Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet. 1994;55(3):505–12.PubMed CentralPubMedGoogle Scholar
- Heilstedt HA, Ballif BC, Howard LA, Lewis RA, Stal S, Kashork CD, et al. Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet. 2003;72(5):1200–12.View ArticlePubMed CentralPubMedGoogle Scholar
- Ballif BC, Wakui K, Gajecka M, Shaffer LG. Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements. Hum Genet. 2004;114(2):198–206.View ArticlePubMedGoogle Scholar
- Feenstra I, Vissers LE, Orsel M, van Kessel AG, Brunner HG, Veltman JA, et al. Genotype-phenotype mapping of chromosome 18q deletions by high-resolution array CGH: an update of the phenotypic map. Am J Med Genet A. 2007;143A(16):1858–67.View ArticlePubMedGoogle Scholar
- Knight SJ, Regan R, Nicod A, Horsley SW, Kearney L, Homfray T, et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet. 1999;354(9191):1676–81.View ArticlePubMedGoogle Scholar
- Knight SJ, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S, et al. An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet. 2000;67(2):320–32.View ArticlePubMed CentralPubMedGoogle Scholar
- Fortin F, Beaulieu Bergeron M, Fetni R, Lemieux N. Frequency of chromosome healing and interstitial telomeres in 40 cases of constitutional abnormalities. Cytogenet Genome Res. 2009;125(3):176–85.View ArticlePubMedGoogle Scholar
- Heard PL, Carter EM, Crandall AC, Sebold C, Hale DE, Cody JD. High resolution genomic analysis of 18q- using oligo-microarray comparative genomic hybridization (aCGH). Am J Med Genet A. 2009;149A(7):1431–7.View ArticlePubMed CentralPubMedGoogle Scholar
- Hannes F, Van Houdt J, Quarrell OW, Poot M, Hochstenbach R, Fryns JP, et al. Telomere healing following DNA polymerase arrest-induced breakages is likely the main mechanism generating chromosome 4p terminal deletions. Hum Mutat. 2010;31(12):1343–51.View ArticlePubMedGoogle Scholar
- Bonaglia MC, Giorda R, Beri S, De Agostini C, Novara F, Fichera M, et al. Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome. PLoS Genet. 2011;7(7), e1002173.View ArticlePubMed CentralPubMedGoogle Scholar
- Katz SG, Schneider SS, Bartuski A, Trask BJ, Massa H, Overhauser J, et al. An 18q- syndrome breakpoint resides between the duplicated serpins SCCA1 and SCCA2 and arises via a cryptic rearrangement with satellite III DNA. Hum Mol Genet. 1999;8(1):87–92.View ArticlePubMedGoogle Scholar
- Luo Y, Hermetz KE, Jackson JM, Mulle JG, Dodd A, Tsuchiya KD, et al. Diverse mutational mechanisms cause pathogenic subtelomeric rearrangements. Hum Mol Genet. 2011;20(19):3769–78.View ArticlePubMed CentralPubMedGoogle Scholar
- Linardopoulou EV, Williams EM, Fan Y, Friedman C, Young JM, Trask BJ. Human subtelomeres are hot spots of interchromosomal recombination and segmental duplication. Nature. 2005;437(7055):94–100.View ArticlePubMed CentralPubMedGoogle Scholar
- Bose P, Hermetz KE, Conneely KN, Rudd MK. Tandem repeats and G-rich sequences are enriched at human CNV breakpoints. PLoS One. 2014;9(7), e101607.View ArticlePubMed CentralPubMedGoogle Scholar
- Ballif BC, Gajecka M, Shaffer LG. Monosomy 1p36 breakpoints indicate repetitive DNA sequence elements may be involved in generating and/or stabilizing some terminal deletions. Chromosome Res. 2004;12(2):133–41.View ArticlePubMedGoogle Scholar
- Harrington LA, Greider CW. Telomerase primer specificity and chromosome healing. Nature. 1991;353(6343):451–4.View ArticlePubMedGoogle Scholar
- Morin GB. Recognition of a chromosome truncation site associated with alpha-thalassaemia by human telomerase. Nature. 1991;353(6343):454–6.View ArticlePubMedGoogle Scholar
- Bottius E, Bakhsis N, Scherf A. Plasmodium falciparum telomerase: de novo telomere addition to telomeric and nontelomeric sequences and role in chromosome healing. Mol Cell Biol. 1998;18(2):919–25.PubMed CentralPubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.